Indoleamine 2,3-dioxygenase in endometrial cancer: a targetable mechanism of immune resistance in mismatch repair-deficient and intact endometrial carcinomas - Concepedia

Concepedia

Publication | Closed Access

Indoleamine 2,3-dioxygenase in endometrial cancer: a targetable mechanism of immune resistance in mismatch repair-deficient and intact endometrial carcinomas

46

Citations

27

References

2018

Year

Anne M. Mills, Sara Zadeh, Emily A. Sloan, Zachary Chinn, Susan C. Modesitt, Kari L. Ring

Modern Pathology

Oncogenic AgentMedicinePathologyGynecologyImmune ResistanceEndometrial CancerOncologyEndocrine-related CancerIndoleamine 2,3-Dioxygenase

References

	Year	Citations

Page 1